The present study evaluated the efficacy of SOS fusion degree in age estimation for the Iranian population. Previous studies (
17,
22,
23) have reported differences in the time of fusion between different populations due to genetic, geographical, and socioeconomic factors. These factors are known to play a considerable role in age estimation, which can be applied in different related areas, such as forensic science, orthodontics, and surgery, as children undergo different developmental stages until adulthood (
24,
25). The present findings demonstrated that the SOS fusion degree is positively correlated with age in both males and females (P < 0.001).
The degree of SOS fusion has been widely investigated in macroscopic, histological, radiographic, and CT scan studies for age estimation (
9,
10,
24,
25). Because of detailed examinations in CT scans, they have been used more frequently than macroscopic and two-dimensional radiographic methods (
4,
6,
26). Generally, both CT and CBCT scans have advantages, such as high resolution and three-dimensional image acquisition; therefore, the SOS fusion degree can be detected straightforwardly. Besides, CBCT can produce images with good quality and reduced radiation (
27).
Different scoring methods have been suggested for evaluating the status of SOS. In this regard, Bassed et al. introduced a five-stage scoring system with scar formation (
28). Also, based on macroscopic studies, Shirley and Jantz suggested that a fusion scar might persist for decades following fusion (
6); therefore, these scars cannot be regarded as a recent sign of fusion, and they are not applicable for age estimation. Accordingly, in the present study, a four-stage scoring system, recommended by Franklin and Flavel, was employed (
23).
In the current study, the oldest female with an open SOS (stage 0) was 10 years old, whereas the oldest male was 12 years old. The fusion of SOS started about two years earlier in females than males. This finding is consistent with the results of previous studies (
4,
23,
25,
26), which reported that fusion occurred about two years earlier in females. Shirley and Jantz observed that fusion in females occurred four years earlier than males (
6). In another study, the mean age at the onset of puberty was 9.74 years, depending on breast development in the Iranian population (
29), which is very close to the age of stage 1 in the current study (9.57 years). Besides, menarche occurred at a mean age of 12.68 years; similarly, the mean age at SOS fusion stage 2 was 12.25 years in the current study; this stage can be considered as a critical point for mandibular growth modification, as the growth spurt is terminated up to SOS fusion stage 2. On the other hand, since the SOS directly affects maxillary growth (
7), growth modification of maxilla with appliances, such as facemasks, is mostly predictable in SOS fusion stage 0 and stage 1.
Compared to some previous studies, in the present study, the mean age of complete SOS fusion varied in different populations and age groups. In the modern Australian population, Bassed et al. reported complete fusion at the age of 17 for males and females (
28). In another study, the mean age of fusion in the Turkish population was 18.21 years in females and 20.02 years in males (
18). Moreover, in the modern American population, the corresponding age was 15.25 years in females and 16.41 years in males (
22). In the current study on the Iranian population, the mean age of complete fusion was 20.25 years in females and 20.34 years in males. In line with the results of studies by Can et al. and Sinanoglu et al., the current study reported a similar age range, with a significant difference between females and males, which might be due to sex differences in skeletal growth cessation (
4,
18).
The measured r
2 value in the present study indicated the fitness of the model. The r
2 value normally ranges from zero to one. As discussed earlier, when this value is close to one, it indicates that the model can significantly explain the total variance in the dependent variable (y). In the current study, the r
2 values were 0.71 and 0.8 for females and males, respectively, which indicated the better fitness of the model for the data as compared to previous studies (
4,
30). Moreover, the results of one-way ANOVA showed a significant difference in males in different age groups; in other words, with an increase in the fusion stage, the mean age increased, which is consistent with the results of a study by Akhlaghi et al. (
24). On the other hand, the mean age of individuals with SOS fusion stage 3 was higher than that of individuals with SOS fusion stage 2; also, the mean age of cases with SOS fusion stage 2 was higher than that of cases with SOS fusion stage 1.
According to a cadaveric study on the Iranian population, Akhlaghi et al. found mean ages of 19.44 and 21.17 years for complete fusion in females and males, respectively. Also, the minimum and maximum age for complete fusion was 12 - 26 years in females and 15 - 26 years in males (
24). In the same population, based on our CBCT evaluation, a mean age of 20.25 years (age range, 12 - 25 years) for females and a mean age of 20.34 years (age range, 16 - 25 years) for males were reported for complete fusion. Considering the similar ethnicity of the groups, these results may indicate the potential of CBCT to estimate age. According to the current results, it is suggested to use SOS for age estimation when CBCT is available for diagnosis. However, further studies are recommended on the relationship between SOS fusion and skeletal age to approve these findings.
In conclusion, a four-stage system could be used for the Iranian population, aged 6 - 25 years, to estimate the age of SOS fusion. The fusion of SOS was positively correlated with age in the Iranian population, and its fusion started earlier in females than males (about two years). Considering the SOS stage, the linear regression model presented age estimation formulae which are applicable for the Iranian population. This estimation may be also valid for orthodontists and clinicians to plan a reliable treatment for patients.